Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-21-025768

COO and Secretary sold 10,000 shares at an average $56.09 ($560,901)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Schuth Alexander O. COO and Secretary 2021-04-05 Sale −5,144 $55.60 $286,027 526,438 I
Schuth Alexander O. COO and Secretary 2021-04-05 Sale −4,156 $56.47 $234,669 522,282 I
Schuth Alexander O. COO and Secretary 2021-04-05 Sale −700 $57.44 $40,206 521,582 I
Open-market sales · 10,000 sh · avg $56.09 · $560,901
Loading xslF345X03/doc4.xml…